These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
474 related items for PubMed ID: 1628156
1. Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol. Karoum F, Egan MF. Br J Pharmacol; 1992 Mar; 105(3):703-7. PubMed ID: 1628156 [Abstract] [Full Text] [Related]
2. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. Karoum F, Chrapusta SJ, Egan MF. J Neurochem; 1994 Sep; 63(3):972-9. PubMed ID: 7914228 [Abstract] [Full Text] [Related]
3. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats. Invernizzi R, Morali F, Pozzi L, Samanin R. Br J Pharmacol; 1990 Aug; 100(4):774-8. PubMed ID: 2207499 [Abstract] [Full Text] [Related]
4. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine. Meltzer HY, Chai BL, Thompson PA, Yamamoto BK. J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957 [Abstract] [Full Text] [Related]
5. Effects of acute and chronic clozapine and haloperidol administration on 3-methoxytyramine accumulation in rat prefrontal cortex, nucleus accumbens and striatum. Egan MF, Karoum F, Wyatt RJ. Eur J Pharmacol; 1991 Jun 25; 199(2):191-9. PubMed ID: 1954977 [Abstract] [Full Text] [Related]
6. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens. Ichikawa J, Meltzer HY. J Pharmacol Exp Ther; 1991 Jan 25; 256(1):348-57. PubMed ID: 1703232 [Abstract] [Full Text] [Related]
7. gamma-Butyrolactone-sensitive and -insensitive dopamine release, and their relationship to dopamine metabolism in three rat brain regions. Chrapusta SJ, Karoum F, Egan MF, Wyatt RJ. Eur J Pharmacol; 1992 Nov 03; 222(1):129-35. PubMed ID: 1468488 [Abstract] [Full Text] [Related]
8. Haloperidol and clozapine increase intraneuronal dopamine metabolism, but not gamma-butyrolactone-resistant dopamine release. Chrapusta SJ, Karoum F, Egan MF, Wyatt RJ. Eur J Pharmacol; 1993 Mar 16; 233(1):135-42. PubMed ID: 8472742 [Abstract] [Full Text] [Related]
9. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism. Gray AM, Connick JH. Eur J Pharmacol; 1998 Dec 04; 362(2-3):127-36. PubMed ID: 9874162 [Abstract] [Full Text] [Related]
10. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum. Rivest R, Marsden CA. Synapse; 1992 Jan 04; 10(1):71-8. PubMed ID: 1371367 [Abstract] [Full Text] [Related]
11. Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol. Rivest R, Marsden CA. Br J Pharmacol; 1991 Sep 04; 104(1):234-8. PubMed ID: 1786513 [Abstract] [Full Text] [Related]
12. The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis. Ichikawa J, Meltzer HY. Eur J Pharmacol; 1990 Feb 13; 176(3):371-4. PubMed ID: 2184042 [Abstract] [Full Text] [Related]
13. Alterations in dopamine metabolism by intraperitoneal ethanol in rats selected for high and low ethanol preference: a 3-methoxytyramine study. Honkanen A, Chrapusta SJ, Karoum F, Korpi ER. Alcohol; 1994 Feb 13; 11(4):323-8. PubMed ID: 7945987 [Abstract] [Full Text] [Related]
14. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. Moghaddam B, Bunney BS. J Neurochem; 1990 May 13; 54(5):1755-60. PubMed ID: 1969939 [Abstract] [Full Text] [Related]
15. Halothane attenuated haloperidol and enhanced clozapine-induced dopamine release in the rat striatum. Adachi YU, Aramaki Y, Satomoto M, Higuchi H, Watanabe K. Neurochem Int; 2003 Jul 13; 43(2):113-9. PubMed ID: 12620279 [Abstract] [Full Text] [Related]
16. Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis. Hernandez L, Hoebel BG. Brain Res Bull; 1989 Apr 13; 22(4):763-9. PubMed ID: 2736403 [Abstract] [Full Text] [Related]
17. Enhancement of dopamine metabolism in rat brain frontal cortex: a common effect of chronically administered antipsychotic drugs. Mefford IN, Roth KA, Agren H, Barchas JD. Brain Res; 1988 Dec 20; 475(2):380-4. PubMed ID: 2905626 [Abstract] [Full Text] [Related]
18. Differential effects of chronic treatment with haloperidol and clozapine on the level of preprosomatostatin mRNA in the striatum, nucleus accumbens, and frontal cortex of the rat. Salin P, Mercugliano M, Chesselet MF. Cell Mol Neurobiol; 1990 Mar 20; 10(1):127-44. PubMed ID: 1970756 [Abstract] [Full Text] [Related]
19. Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytramine. Ponzio F, Achilli G, Perego C, Algeri S. Neurosci Lett; 1981 Nov 18; 27(1):61-7. PubMed ID: 7329624 [Abstract] [Full Text] [Related]
20. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo. Ichikawa J, Meltzer HY. Brain Res; 1992 Mar 06; 574(1-2):98-104. PubMed ID: 1379112 [Abstract] [Full Text] [Related] Page: [Next] [New Search]